Assessing Changes in Hand Tactile Sensitivity After Glabellar Botulinum Toxin Treatment.
Abstract
[PURPOSE] The authors aimed to assess behavioral changes in tactile sensitivity in patients receiving cosmetic glabellar botulinum toxin-A injections.
[METHODS] In this prospective cohort study, the authors conducted quantitative sensory testing on 20 patients receiving 15 to 35 units of glabellar botulinum toxin-A treatment between October 1, 2022 and March 8, 2023. The authors used modified Von Frey filaments to exert forces between 0.25 mN and 512 mN to the dorsal hand just prior to botulinum toxin-A injections. Filament tips were uniform, rounded, and 0.5 mm in diameter to prevent nociceptor activation. This process was repeated 4 to 6 weeks after injection to assess for any change in minimal mechanical detection thresholds.
[RESULTS] Minimal mechanical detection thresholds decreased (patients detected smaller amounts of force) overall, in patients with prior botulinum toxin-A treatment, and in patients without prior botulinum toxin-A treatment: 5.34 mN to 4.33 mN ( p = 0.22), 6.43 mN to 5.97 mN ( p = 0.31), and 4.44 mN to 3.00 mN ( p = 0.53), respectively.
[CONCLUSIONS] The authors' results suggest that the plastic changes observed in previous studies do not necessarily result in clinically significant manifestations when utilizing small to moderate amounts of botulinum toxin-A for aesthetic correction of glabellar lines, thus highlighting the safety of botulinum toxin-A for this indication. Further research is required to gain a comprehensive understanding of whether hand-associated cortical activity is altered after aesthetic amounts of botulinum toxin are injected.
[METHODS] In this prospective cohort study, the authors conducted quantitative sensory testing on 20 patients receiving 15 to 35 units of glabellar botulinum toxin-A treatment between October 1, 2022 and March 8, 2023. The authors used modified Von Frey filaments to exert forces between 0.25 mN and 512 mN to the dorsal hand just prior to botulinum toxin-A injections. Filament tips were uniform, rounded, and 0.5 mm in diameter to prevent nociceptor activation. This process was repeated 4 to 6 weeks after injection to assess for any change in minimal mechanical detection thresholds.
[RESULTS] Minimal mechanical detection thresholds decreased (patients detected smaller amounts of force) overall, in patients with prior botulinum toxin-A treatment, and in patients without prior botulinum toxin-A treatment: 5.34 mN to 4.33 mN ( p = 0.22), 6.43 mN to 5.97 mN ( p = 0.31), and 4.44 mN to 3.00 mN ( p = 0.53), respectively.
[CONCLUSIONS] The authors' results suggest that the plastic changes observed in previous studies do not necessarily result in clinically significant manifestations when utilizing small to moderate amounts of botulinum toxin-A for aesthetic correction of glabellar lines, thus highlighting the safety of botulinum toxin-A for this indication. Further research is required to gain a comprehensive understanding of whether hand-associated cortical activity is altered after aesthetic amounts of botulinum toxin are injected.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 9 | |
| 해부 | Glabellar Botulinum Toxin
|
scispacy | 1 | ||
| 해부 | glabellar botulinum toxin-A injections
|
scispacy | 1 | ||
| 해부 | glabellar botulinum toxin-A
|
scispacy | 1 | ||
| 해부 | dorsal
|
scispacy | 1 | ||
| 해부 | glabellar lines
|
scispacy | 1 | ||
| 약물 | Filament
|
scispacy | 1 | ||
| 약물 | [CONCLUSIONS]
|
scispacy | 1 | ||
| 질환 | hand-associated cortical
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | botulinum toxin-A
|
scispacy | 1 |
MeSH Terms
Humans; Botulinum Toxins, Type A; Prospective Studies; Female; Neuromuscular Agents; Male; Middle Aged; Hand; Adult; Forehead; Touch; Sensory Thresholds; Skin Aging; Aged
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.
- Current Perspectives on Pectoralis Minor Syndrome: A Narrative Review.